Jason Held - Publications

Affiliations: 
2015-2015 Oncology Washington University, Saint Louis, St. Louis, MO 

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Huang KL, Wu Y, Primeau T, Wang YT, Gao Y, McMichael JF, Scott AD, Cao S, Wendl MC, Johnson KJ, Ruggles K, Held J, Payne SH, Davies SR, Dar A, et al. Regulated Phosphosignaling Associated with Breast Cancer Subtypes and Druggability. Molecular & Cellular Proteomics : McP. PMID 31196969 DOI: 10.1074/Mcp.Ra118.001243  0.331
2018 Behring J, van der Post S, Mooradian A, Egan M, Held J. EGF regulates biologically organized cysteine redox networks with distinct spatiotemporal dynamics Free Radical Biology and Medicine. 128: S62. DOI: 10.1016/J.Freeradbiomed.2018.10.123  0.391
2017 Collins BC, Hunter CL, Liu Y, Schilling B, Rosenberger G, Bader SL, Chan DW, Gibson BW, Gingras AC, Held JM, Hirayama-Kurogi M, Hou G, Krisp C, Larsen B, Lin L, et al. Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry. Nature Communications. 8: 291. PMID 28827567 DOI: 10.1038/S41467-017-00249-5  0.559
2017 Huang KL, Li S, Mertins P, Cao S, Gunawardena HP, Ruggles KV, Mani DR, Clauser KR, Tanioka M, Usary J, Kavuri SM, Xie L, Yoon C, Qiao JW, Wrobel J, ... ... Held JM, et al. Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nature Communications. 8: 14864. PMID 28348404 DOI: 10.1038/Ncomms14864  0.35
2015 Schilling B, MacLean B, Held JM, Sahu AK, Rardin MJ, Sorensen DJ, Peters T, Wolfe AJ, Hunter CL, MacCoss MJ, Gibson BW. Multiplexed, Scheduled, High-Resolution Parallel Reaction Monitoring on a Full Scan QqTOF Instrument with Integrated Data-Dependent and Targeted Mass Spectrometric Workflows. Analytical Chemistry. PMID 26398777 DOI: 10.1021/Acs.Analchem.5B02983  0.561
2015 Abbatiello SE, Schilling B, Mani DR, Zimmerman LJ, Hall SC, MacLean B, Albertolle M, Allen S, Burgess M, Cusack MP, Ghosh M, Hedrick V, Held JM, Inerowicz HD, Jackson A, et al. Large-scale inter-laboratory study to develop, analytically validate and apply highly multiplexed, quantitative peptide assays to measure cancer-relevant proteins in plasma. Molecular & Cellular Proteomics : McP. PMID 25693799 DOI: 10.1074/Mcp.M114.047050  0.587
2015 Mundt FO, Ma C, Mertins P, Guo Z, Meyer M, Qiao J, Mani, Clauser K, Li S, Huang K, Held J, Davies S, Ruggles K, Ding L, Gillette M, et al. Abstract C200: Effects of PI3K/Akt pathway inhibition on global proteome levels and phosphorylation signaling in patient-derived xenograft models of triple negative breast cancer Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-C200  0.383
2014 Post DM, Held JM, Ketterer MR, Phillips NJ, Sahu A, Apicella MA, Gibson BW. Comparative analyses of proteins from Haemophilus influenzae biofilm and planktonic populations using metabolic labeling and mass spectrometry. Bmc Microbiology. 14: 329. PMID 25551439 DOI: 10.1186/S12866-014-0329-9  0.526
2014 Wilson-Edell KA, Kehasse A, Scott GK, Yau C, Rothschild DE, Schilling B, Gabriel BS, Yevtushenko MA, Hanson IM, Held JM, Gibson BW, Benz CC. RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth. Oncotarget. 5: 5165-76. PMID 24970821 DOI: 10.18632/Oncotarget.2099  0.525
2014 Zawadzka AM, Schilling B, Held JM, Sahu AK, Cusack MP, Drake PM, Fisher SJ, Gibson BW. Variation and quantification among a target set of phosphopeptides in human plasma by multiple reaction monitoring and SWATH-MS2 data-independent acquisition. Electrophoresis. 35: 3487-97. PMID 24853916 DOI: 10.1002/Elps.201400167  0.575
2013 Rardin MJ, Held JM, Gibson BW. Targeted quantitation of acetylated lysine peptides by selected reaction monitoring mass spectrometry. Methods in Molecular Biology (Clifton, N.J.). 1077: 121-31. PMID 24014403 DOI: 10.1007/978-1-62703-637-5_8  0.538
2013 Held JM, Schilling B, D'Souza AK, Srinivasan T, Behring JB, Sorensen DJ, Benz CC, Gibson BW. Label-Free Quantitation and Mapping of the ErbB2 Tumor Receptor by Multiple Protease Digestion with Data-Dependent (MS1) and Data-Independent (MS2) Acquisitions. International Journal of Proteomics. 2013: 791985. PMID 23710360 DOI: 10.1155/2013/791985  0.58
2013 Abbatiello SE, Mani DR, Schilling B, Maclean B, Zimmerman LJ, Feng X, Cusack MP, Sedransk N, Hall SC, Addona T, Allen S, Dodder NG, Ghosh M, Held JM, Hedrick V, et al. Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS). Molecular & Cellular Proteomics : McP. 12: 2623-39. PMID 23689285 DOI: 10.1074/Mcp.M112.027078  0.555
2013 Rardin MJ, Newman JC, Held JM, Cusack MP, Sorensen DJ, Li B, Schilling B, Mooney SD, Kahn CR, Verdin E, Gibson BW. Label-free quantitative proteomics of the lysine acetylome in mitochondria identifies substrates of SIRT3 in metabolic pathways. Proceedings of the National Academy of Sciences of the United States of America. 110: 6601-6. PMID 23576753 DOI: 10.1073/Pnas.1302961110  0.555
2012 Held JM, Britton DJ, Scott GK, Lee EL, Schilling B, Baldwin MA, Gibson BW, Benz CC. Ligand binding promotes CDK-dependent phosphorylation of ER-alpha on hinge serine 294 but inhibits ligand-independent phosphorylation of serine 305. Molecular Cancer Research : McR. 10: 1120-32. PMID 22669764 DOI: 10.1158/1541-7786.Mcr-12-0099  0.488
2012 Zhang N, Li B, Al-Ramahi I, Cong X, Held JM, Kim E, Botas J, Gibson BW, Ellerby LM. Inhibition of lipid signaling enzyme diacylglycerol kinase epsilon attenuates mutant huntingtin toxicity. The Journal of Biological Chemistry. 287: 21204-13. PMID 22511757 DOI: 10.1074/Jbc.M111.321661  0.459
2012 Drake PM, Schilling B, Niles RK, Prakobphol A, Li B, Jung K, Cho W, Braten M, Inerowicz HD, Williams K, Albertolle M, Held JM, Iacovides D, Sorensen DJ, Griffith OL, et al. Lectin chromatography/mass spectrometry discovery workflow identifies putative biomarkers of aggressive breast cancers. Journal of Proteome Research. 11: 2508-20. PMID 22309216 DOI: 10.1021/Pr201206W  0.695
2012 Held JM, Gibson BW. Regulatory control or oxidative damage? Proteomic approaches to interrogate the role of cysteine oxidation status in biological processes. Molecular & Cellular Proteomics : McP. 11: R111.013037. PMID 22159599 DOI: 10.1074/Mcp.R111.013037  0.484
2012 Scott GK, Held J, Britton DJ, Lee E, Schilling B, Baldwin M, Gibson BW, Benz CC. Abstract 3933: ERα phosphorylation patterns at hinge domain Ser294 and Ser305 differentiate ligand-dependent from ligand-independent receptor activation Cancer Research. 72: 3933-3933. DOI: 10.1158/1538-7445.Am2012-3933  0.35
2011 Cong X, Held JM, DeGiacomo F, Bonner A, Chen JM, Schilling B, Czerwieniec GA, Gibson BW, Ellerby LM. Mass spectrometric identification of novel lysine acetylation sites in huntingtin. Molecular & Cellular Proteomics : McP. 10: M111.009829. PMID 21685499 DOI: 10.1074/Mcp.M111.009829  0.553
2011 Lucanic M, Held JM, Vantipalli MC, Klang IM, Graham JB, Gibson BW, Lithgow GJ, Gill MS. N-acylethanolamine signalling mediates the effect of diet on lifespan in Caenorhabditis elegans. Nature. 473: 226-9. PMID 21562563 DOI: 10.1038/Nature10007  0.447
2011 Li B, Held JM, Schilling B, Danielson SR, Gibson BW. Confident identification of 3-nitrotyrosine modifications in mass spectral data across multiple mass spectrometry platforms. Journal of Proteomics. 74: 2510-21. PMID 21514405 DOI: 10.1016/J.Jprot.2011.04.007  0.542
2011 Danielson SR, Held JM, Oo M, Riley R, Gibson BW, Andersen JK. Quantitative mapping of reversible mitochondrial Complex I cysteine oxidation in a Parkinson disease mouse model. The Journal of Biological Chemistry. 286: 7601-8. PMID 21196577 DOI: 10.1074/Jbc.M110.190108  0.462
2011 Scott GK, Gabriel B, Held J, Lee E, Benz CC. Abstract 1626: Polyribosome-associated proteins targeted by HDACi promote the selective degradation of oncogenic transcripts Cancer Research. 71: 1626-1626. DOI: 10.1158/1538-7445.Am2011-1626  0.421
2010 Marx C, Held JM, Gibson BW, Benz CC. ErbB2 trafficking and degradation associated with K48 and K63 polyubiquitination. Cancer Research. 70: 3709-17. PMID 20406983 DOI: 10.1158/0008-5472.Can-09-3768  0.474
2010 Held JM, Danielson SR, Behring JB, Atsriku C, Britton DJ, Puckett RL, Schilling B, Campisi J, Benz CC, Gibson BW. Targeted quantitation of site-specific cysteine oxidation in endogenous proteins using a differential alkylation and multiple reaction monitoring mass spectrometry approach. Molecular & Cellular Proteomics : McP. 9: 1400-10. PMID 20233844 DOI: 10.1074/Mcp.M900643-Mcp200  0.539
2010 Scott GK, Gabriel B, Held J, Benz CC. Abstract 1245: Polyribosome association of tyrosine phosphorylated RACK1 with activated Src regulates translation of specific proteins mediating breast cancer growth and metastasis Cancer Research. 70: 1245-1245. DOI: 10.1158/1538-7445.Am10-1245  0.396
2009 Danielson SR, Held JM, Schilling B, Oo M, Gibson BW, Andersen JK. Preferentially increased nitration of alpha-synuclein at tyrosine-39 in a cellular oxidative model of Parkinson's disease. Analytical Chemistry. 81: 7823-8. PMID 19697948 DOI: 10.1021/Ac901176T  0.492
2009 Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM, Spiegelman CH, Zimmerman LJ, Ham AJ, Keshishian H, Hall SC, Allen S, Blackman RK, Borchers CH, Buck C, ... ... Held JM, et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nature Biotechnology. 27: 633-41. PMID 19561596 DOI: 10.1038/Nbt.1546  0.697
2009 Atsriku C, Britton DJ, Held JM, Schilling B, Scott GK, Gibson BW, Benz CC, Baldwin MA. Systematic mapping of posttranslational modifications in human estrogen receptor-alpha with emphasis on novel phosphorylation sites. Molecular & Cellular Proteomics : McP. 8: 467-80. PMID 18984578 DOI: 10.1074/Mcp.M800282-Mcp200  0.567
2009 Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM, Spiegelman CH, Zimmerman LJ, Ham AL, Keshishian H, Hall SC, Allen S, Blackman RK, Borchers CH, Buck C, ... ... Held JM, et al. Erratum: Corrigendum: Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma Nature Biotechnology. 27: 864-864. DOI: 10.1038/Nbt0909-864B  0.673
2008 Britton DJ, Scott GK, Schilling B, Atsriku C, Held JM, Gibson BW, Benz CC, Baldwin MA. A novel serine phosphorylation site detected in the N-terminal domain of estrogen receptor isolated from human breast cancer cells. Journal of the American Society For Mass Spectrometry. 19: 729-40. PMID 18367407 DOI: 10.1016/J.Jasms.2008.02.008  0.588
2008 Benz C, Marx C, Held J, Gibson B. 310 POSTER ERBB2/HER2 proteasome–lysosome trafficking and degradation directed by polyubiquitination topology European Journal of Cancer Supplements. 6: 99. DOI: 10.1016/s1359-6349(08)72244-4  0.439
2006 Held JM, White MP, Fisher AL, Gibson BW, Lithgow GJ, Gill MS. DAF-12-dependent rescue of dauer formation in Caenorhabditis elegans by (25S)-cholestenoic acid. Aging Cell. 5: 283-91. PMID 16913876 DOI: 10.1111/J.1474-9726.2006.00218.X  0.462
2005 Scott GK, Atsriku C, Kaminker P, Held J, Gibson B, Baldwin MA, Benz CC. Vitamin K3 (menadione)-induced oncosis associated with keratin 8 phosphorylation and histone H3 arylation. Molecular Pharmacology. 68: 606-15. PMID 15939799 DOI: 10.1124/Mol.105.013474  0.535
2004 Gill MS, Held JM, Fisher AL, Gibson BW, Lithgow GJ. Lipophilic regulator of a developmental switch in Caenorhabditis elegans. Aging Cell. 3: 413-21. PMID 15569358 DOI: 10.1111/J.1474-9728.2004.00126.X  0.447
Show low-probability matches.